Iridex Corp
- Last sale
- Nov 11, 2026 · -4.74%
- Market cap
- $11.79M
- 17.56M shares
- Filings
- 1,019
Q2 2026+8.2% FY26 yoy
Q2 2026N/M FY26 yoy
Q2 2026N/M FY26 yoy
Q2 2026derivedN/M FY26 yoy
Q2 2026N/M FY26 yoy
Q2 2026+152.5% FY25 yoy
- $11.79M
- —
- 0.2×
- 3.2×
- -16.96%
- —
Twelve months to Jul 4, 2026 · derived
Price
Nov 11, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-01-03 | $52,675,000 | reported | |
| FY 2024 | 2024-12-28 | $48,669,000 | reported | |
| FY 2023 | 2023-12-30 | $51,869,000 | reported | |
| FY 2022 | 2022-12-31 | $56,972,000 | reported | |
| FY 2021 | 2022-01-01 | $53,903,000 | reported | |
| FY 2020 | 2021-01-02 | $36,347,000 | reported | |
| FY 2019 | 2019-12-28 | $43,447,000 | reported | |
| FY 2018 | 2018-12-29 | $42,600,000 | reported | |
| FY 2017 | 2017-12-30 | $41,593,000 | reported | |
| FY 2016 | 2016-12-31 | $46,158,000 | reported | |
| FY 2015 | 2016-01-02 | $41,757,000 | reported | |
| FY 2014 | 2015-01-03 | $42,814,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2016 | — | $59.00K | $59.00K | — | 11.52M sh | +14.6% | — |
| FY2015 | — | $1.56M | $1.56M | — | 10.05M sh | +2.0% | — |
| FY2014 | — | $4.67M | $4.67M | — | 9.86M sh | −1.4% | 135.4% |
| FY2013 | — | $426.00K | $426.00K | — | 9.99M sh | +16.8% | 110.1% |
| FY2012 | — | $2.84M | $2.84M | — | 8.55M sh | −4.3% | — |
Segments
LineFY2026ShareChange
United States$23.21M44%+2.3%
Europe, Middle East and Africa$14.39M27%+21.7%
Asia/Pacific Rim$12.95M25%+8.4%
Americas, excluding the U.S.$2.12M4.0%−3.8%
Europe———
Total$52.68M
Electromedical & electrotherapeutic apparatus
Iridex Corp is the 13th largest of the 31 covered companies the SEC files under this code, by revenue. SIC 3845
CompanyRevenueGrowthNet marginMarket cap
OMOutset Medical, Inc.$119.5M5.1%68.3%$73.4MVASOVaso Corp$89.1M2.7%1.8%$54.6MCBLLCeribell, Inc.$89.1M36.1%60.0%$1.1BELMDElectromed, Inc.$73.8M15.3%15.3%$234.0MFOCLEdap TMS SA$70.5M1.6%41.5%$162.9M
IRIXIridex Corp (this company)$52.7M8.2%8.4%$11.8M
STXSStereotaxis, Inc.$32.4M20.3%66.8%$85.0MECORelectroCore, Inc.$32.0M27.2%43.6%$48.1MPOCIPrecision Optics Corporation, Inc.$31.5M65.2%11.5%$52.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Iridex Corp · CIK 1006045 · Engraved from SEC EDGAR